Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature. - Wikidata - awgldk - TriplyDB

Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.

Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.

http://www.wikidata.org/entity/Q37461447

about

Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative?Clopidogrel-induced liver failure.Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.Clopidogrel-Induced Severe Hepatitis: A Case Report and Literature Review.The mechanism and risk factors of clopidogrel-induced liver injury.Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells.

P2860

Q33396814-BCA976BA-E941-4DDF-A8FD-5A6A696AB4B6 Q35017980-AB283221-4D05-4C48-8A05-BAAB5A29F7DD Q35843262-E6E76122-970C-45C9-BE3D-BE9B8AE160A7 Q37724173-7BE4AE51-DFFB-4367-B344-637735895689 Q38901104-EFDC75B0-B1B8-4D2A-98CF-F691607B971A Q46625831-5DA317B5-BE8B-4058-B5EC-4642F4614DED Q47335450-B65330C5-D263-471D-B0CA-0D96F8231153

P2860

Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.

http://www.wikidata.org/entity/Q37461447

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clopidogrel-induced hepatocell ...... and review of the literature.

@en

Clopidogrel-induced hepatocell ...... and review of the literature.

@nl

type

label

Clopidogrel-induced hepatocell ...... and review of the literature.

@en

Clopidogrel-induced hepatocell ...... and review of the literature.

@nl

prefLabel

Clopidogrel-induced hepatocell ...... and review of the literature.

@en

Clopidogrel-induced hepatocell ...... and review of the literature.

@nl

P1433

Q37461447-3DAE423B-9556-4CD9-B87C-46B4B33A94F8

P1476

Q37461447-44F9D131-C049-4531-8809-8EBB14F06CBA

P2093

Q37461447-0077E76B-F076-406A-AB86-029D7354CF3E

Q37461447-8F1C5BC4-B60B-43A6-9837-DA58AE4ACC93

Q37461447-D8D0A103-EAB7-4206-B9C2-6559D7BA6368

P2860

Q37461447-0DEC8F9C-FB0C-4AB9-9DF6-060103952E5A

Q37461447-11B4028E-10B7-4B9F-A542-30E1AD3F34B6

Q37461447-2A493024-59FE-4CF3-A064-6908EB1E7D50

Q37461447-3899DCC8-1DBE-4955-B39E-B3F069B5E1FC

Q37461447-54D7EC9F-4CB3-42DF-B7B1-71FCDA727543

Q37461447-62A4987B-B792-4CF7-90DF-9BE868A1889B

Q37461447-664E1426-A1D3-441B-9618-34074987056F

Q37461447-77320BA7-28AC-4C67-BD59-ABC79FD298D5

Q37461447-7F1659F4-F10A-4C49-88E7-2406871C18AC

Q37461447-99480ABD-DD2C-468C-9BDD-2D755B548CCB

P304

Q37461447-A179BA35-BE56-47D4-AA33-EE53A54512D0

P31

Q37461447-C3B3E71A-025E-4604-9143-A74DA21C68D9

P356

Q37461447-100013BA-2386-447B-A78C-36EE73E240B1

P407

Q37461447-1BD948DB-5E9C-4A59-BEB1-8CAB92B43769

P433

Q37461447-807C9CA5-3CEE-40E5-90F6-5CA0B92754F9

P478

Q37461447-A347DD87-755A-4956-BCAC-148D2827C758

P577

Q37461447-EC0C9B6F-EA8A-4287-85D5-DFBFADE4CD63

P698

Q37461447-19462352-AB32-4B99-ACF9-A86736F3ECB8

P921

Q37461447-58114321-5C58-40CE-9B17-DB3210E6BE1F

Q37461447-A65D73A7-718E-4DE1-BF92-7A798C9700BB

P356

P1433

Pharmacotherapy

P1476

Clopidogrel-induced hepatocell ...... and review of the literature.

@en

P2093

Dimple Srivastava

http://www.w3.org/2001/XMLSchema#string

Klaus-Dieter Lessnau

http://www.w3.org/2001/XMLSchema#string

Rakesh K Goyal

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Clopidogrel-induced systemic inflammatory response syndrome

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Drug-induced hepatotoxicity.

Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.

P304

608-612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.29.5.608

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19397467

http://www.w3.org/2001/XMLSchema#string

P921